Header Logo

Connection

MARIA REDONDO to Female

Back to Details
This is a "connection" page, showing publications MARIA REDONDO has written about Female.
MARIA REDONDO
Connection Strength
1.118
Female
  1. Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention. Diabetes Care. 2026 Feb 01; 49(2):344-351.
    View in: PubMed
    Score: 0.036
  2. Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):e1046-e1050.
    View in: PubMed
    Score: 0.034
  3. Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes. Diabetologia. 2025 Mar; 68(3):588-601.
    View in: PubMed
    Score: 0.034
  4. Age and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2025 Jan 29; 38(1):22-28.
    View in: PubMed
    Score: 0.034
  5. Diabetic ketoacidosis in youth with diabetes mellitus during the COVID-19 pandemic. J Pediatr Endocrinol Metab. 2024 Sep 25; 37(9):759-763.
    View in: PubMed
    Score: 0.033
  6. Inaccurate diagnosis of diabetes type in youth: prevalence, characteristics, and implications. Sci Rep. 2024 04 17; 14(1):8876.
    View in: PubMed
    Score: 0.032
  7. Elevated Serum IgA at Onset of Type 1 Diabetes in Children. Pediatr Diabetes. 2024; 2024:7284088.
    View in: PubMed
    Score: 0.032
  8. Clinical Characterization of Data-Driven Diabetes Clusters of Pediatric Type 2 Diabetes. Pediatr Diabetes. 2023; 2023.
    View in: PubMed
    Score: 0.031
  9. Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. Diabetologia. 2023 01; 66(1):127-131.
    View in: PubMed
    Score: 0.029
  10. On the road to universal screening for risk of type 1 diabetes. Lancet Diabetes Endocrinol. 2022 08; 10(8):554-555.
    View in: PubMed
    Score: 0.028
  11. Type 2 diabetes in prepubertal children. Pediatr Diabetes. 2021 11; 22(7):946-950.
    View in: PubMed
    Score: 0.027
  12. Islet autoantibody types mark differential clinical characteristics at diagnosis of pediatric type 1 diabetes. Pediatr Diabetes. 2021 09; 22(6):882-888.
    View in: PubMed
    Score: 0.026
  13. Index60 as an additional diagnostic criterion for type 1 diabetes. Diabetologia. 2021 04; 64(4):836-844.
    View in: PubMed
    Score: 0.026
  14. Sex differences in circulating leptin as a marker of adiposity in obese or overweight adolescents with type 1 diabetes. BMJ Open Diabetes Res Care. 2020 10; 8(1).
    View in: PubMed
    Score: 0.025
  15. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance. J Clin Endocrinol Metab. 2020 05 01; 105(5).
    View in: PubMed
    Score: 0.024
  16. Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2018 12; 41(12):2480-2486.
    View in: PubMed
    Score: 0.022
  17. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care. 2018 09; 41(9):1887-1894.
    View in: PubMed
    Score: 0.022
  18. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care. 2018 05; 41(5):1017-1024.
    View in: PubMed
    Score: 0.021
  19. TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care. 2018 02; 41(2):311-317.
    View in: PubMed
    Score: 0.020
  20. Racial and ethnic differences among children with new-onset autoimmune Type 1 diabetes. Diabet Med. 2017 10; 34(10):1435-1439.
    View in: PubMed
    Score: 0.020
  21. Diabetes care provider perceptions on family challenges of pediatric type 1 diabetes. Diabetes Res Clin Pract. 2017 Jul; 129:203-205.
    View in: PubMed
    Score: 0.020
  22. Serum undercarboxylated osteocalcin correlates with hemoglobin A1c in children with recently diagnosed pediatric diabetes. Pediatr Diabetes. 2017 Dec; 18(8):869-873.
    View in: PubMed
    Score: 0.019
  23. Dissecting heterogeneity in paediatric Type 1 diabetes: association of TCF7L2 rs7903146 TT and low-risk human leukocyte antigen (HLA) genotypes. Diabet Med. 2017 02; 34(2):286-290.
    View in: PubMed
    Score: 0.018
  24. Psychosocial aspects of type 1 diabetes in Latino- and Asian-American youth. Pediatr Res. 2016 09; 80(3):347-55.
    View in: PubMed
    Score: 0.018
  25. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes. Diabet Med. 2017 05; 34(5):641-646.
    View in: PubMed
    Score: 0.018
  26. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index. Acta Diabetol. 2016 Apr; 53(2):271-7.
    View in: PubMed
    Score: 0.017
  27. Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2014 Dec; 15(8):543-9.
    View in: PubMed
    Score: 0.016
  28. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis. Pediatr Diabetes. 2014 Jun; 15(4):294-302.
    View in: PubMed
    Score: 0.015
  29. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis. Pediatr Diabetes. 2013 Aug; 14(5):333-40.
    View in: PubMed
    Score: 0.015
  30. LADA: time for a new definition. Diabetes. 2013 Feb; 62(2):339-40.
    View in: PubMed
    Score: 0.015
  31. Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2012 Nov; 13(7):564-71.
    View in: PubMed
    Score: 0.014
  32. A Digital Diabetes Prevention Program for Hispanic Adolescents (Fit24+): Protocol for a Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2026 Apr 15; 15:e75331.
    View in: PubMed
    Score: 0.009
  33. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes. J Clin Endocrinol Metab. 2006 May; 91(5):1705-13.
    View in: PubMed
    Score: 0.009
  34. Maturity-Onset Diabetes of the Young (MODY) in a Racially/Ethnically Diverse Pediatric Population. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e512-e521.
    View in: PubMed
    Score: 0.009
  35. Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e493-e499.
    View in: PubMed
    Score: 0.009
  36. Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression. Diabetes. 2026 01 20; 75(2):389-397.
    View in: PubMed
    Score: 0.009
  37. Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval. Diabetes. 2025 Nov 01; 74(11):2101-2110.
    View in: PubMed
    Score: 0.009
  38. Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study. Diabetes Care. 2025 Sep 01; 48(9):1571-1580.
    View in: PubMed
    Score: 0.009
  39. Development and recalibration?of a?multivariable?type 1 diabetes prediction model for?type 1 diabetes across multiple screening studies. BMC Med. 2025 Jul 21; 23(1):433.
    View in: PubMed
    Score: 0.009
  40. The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes. 2025 Jul 01; 74(7):1196-1204.
    View in: PubMed
    Score: 0.009
  41. The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth. J Clin Endocrinol Metab. 2025 Jun 17; 110(7):e2191-e2197.
    View in: PubMed
    Score: 0.009
  42. Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter. Diabetologia. 2025 Aug; 68(8):1709-1720.
    View in: PubMed
    Score: 0.009
  43. IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. Diabetologia. 2025 May; 68(5):993-1004.
    View in: PubMed
    Score: 0.009
  44. A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts. Diabetes Technol Ther. 2025 03; 27(3):179-186.
    View in: PubMed
    Score: 0.008
  45. Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance. J Endocrinol Invest. 2025 Mar; 48(3):765-775.
    View in: PubMed
    Score: 0.008
  46. Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2024 Dec 01; 47(12):2110-2119.
    View in: PubMed
    Score: 0.008
  47. Identification of atypical pediatric diabetes mellitus cases using electronic medical records. BMJ Open Diabetes Res Care. 2024 Nov 07; 12(6).
    View in: PubMed
    Score: 0.008
  48. Expression of beta-cell autoimmunity does not differ between potential dizygotic twins and siblings of patients with type 1 diabetes. J Autoimmun. 2004 Nov; 23(3):275-9.
    View in: PubMed
    Score: 0.008
  49. Random C-Peptide and Islet Antibodies at Onset Predict ? Cell Function Trajectory and Insulin Dependence in Pediatric Diabetes. Endocr Pract. 2024 Dec; 30(12):1149-1157.
    View in: PubMed
    Score: 0.008
  50. Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes. Pediatr Diabetes. 2024; 2024:8343868.
    View in: PubMed
    Score: 0.008
  51. Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis. Diabetologia. 2024 Nov; 67(11):2507-2517.
    View in: PubMed
    Score: 0.008
  52. Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals. J Clin Endocrinol Metab. 2024 Jul 12; 109(8):2116-2123.
    View in: PubMed
    Score: 0.008
  53. Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes Care. 2024 Jun 01; 47(6):1048-1055.
    View in: PubMed
    Score: 0.008
  54. Variants of Unknown Significance in Maturity-Onset Diabetes of the Young: High Rate of Conundrum Resolution via Variants of Unknown Significance Reanalysis. Horm Res Paediatr. 2025; 98(5):524-531.
    View in: PubMed
    Score: 0.008
  55. High Prevalence of A-?+ Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT). Pediatr Diabetes. 2024; 2024.
    View in: PubMed
    Score: 0.008
  56. Social Determinant of Health Impact on Diabetes Device Use and Clinical Outcomes in Youth with Type 1 Diabetes. Pediatr Diabetes. 2023; 2023:4751595.
    View in: PubMed
    Score: 0.008
  57. Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth. J Pediatr. 2013 Feb; 162(2):330-4.e1.
    View in: PubMed
    Score: 0.007
  58. Exome sequencing in children with clinically suspected maturity-onset diabetes of the young. Pediatr Diabetes. 2021 11; 22(7):960-968.
    View in: PubMed
    Score: 0.007
  59. Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts. Diabetes Care. 2021 10; 44(10):2329-2336.
    View in: PubMed
    Score: 0.007
  60. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001 Mar; 44(3):354-62.
    View in: PubMed
    Score: 0.006
  61. The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis. J Clin Endocrinol Metab. 2020 12 01; 105(12).
    View in: PubMed
    Score: 0.006
  62. Racial-Ethnic Inequity in Young Adults With Type 1 Diabetes. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.006
  63. Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals. Diabetes Obes Metab. 2020 06; 22(6):997-1000.
    View in: PubMed
    Score: 0.006
  64. Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents. Diabetes Care. 2020 03; 43(3):580-587.
    View in: PubMed
    Score: 0.006
  65. Using Relational Agents to Promote Family Communication Around Type 1 Diabetes Self-Management in the Diabetes Family Teamwork Online Intervention: Longitudinal Pilot Study. J Med Internet Res. 2019 09 13; 21(9):e15318.
    View in: PubMed
    Score: 0.006
  66. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer. BMC Cancer. 2019 Jul 25; 19(1):735.
    View in: PubMed
    Score: 0.006
  67. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ. 1999 Mar 13; 318(7185):698-702.
    View in: PubMed
    Score: 0.006
  68. CCR-CARESS score for predicting operative mortality in patients with colorectal cancer. Br J Surg. 2018 12; 105(13):1853-1861.
    View in: PubMed
    Score: 0.005
  69. Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk. Diabetologia. 2018 09; 61(9):2043-2053.
    View in: PubMed
    Score: 0.005
  70. Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: Analysis of the type 1 diabetes Exchange Clinic Registry. Pediatr Diabetes. 2018 06; 19(4):741-748.
    View in: PubMed
    Score: 0.005
  71. Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain. Diabetes Metab. 1997 Dec; 23(6):519-23.
    View in: PubMed
    Score: 0.005
  72. The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults. J Clin Endocrinol Metab. 2017 12 01; 102(12):4596-4603.
    View in: PubMed
    Score: 0.005
  73. Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes? J Clin Endocrinol Metab. 2017 08 01; 102(8):2873-2880.
    View in: PubMed
    Score: 0.005
  74. Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development? Diabetes Care. 2017 05; 40(5):698-701.
    View in: PubMed
    Score: 0.005
  75. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study. Pediatr Diabetes. 2017 Nov; 18(7):566-573.
    View in: PubMed
    Score: 0.005
  76. Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study. Diabetes Care. 2016 Mar; 39(3):465-8.
    View in: PubMed
    Score: 0.005
  77. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care. 2015 Dec; 38(12):2341-3.
    View in: PubMed
    Score: 0.004
  78. Body mass index changes in youth in the first year after type 1 diabetes diagnosis. J Pediatr. 2015 May; 166(5):1265-1269.e1.
    View in: PubMed
    Score: 0.004
  79. An unknown risk group of lead poisoning: the gypsy children. Eur J Pediatr. 1995 Mar; 154(3):197-200.
    View in: PubMed
    Score: 0.004
  80. Prediagnostic intake of dairy products and dietary calcium and colorectal cancer survival--results from the EPIC cohort study. Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1813-23.
    View in: PubMed
    Score: 0.004
  81. The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol. 2013 Dec; 42(6):1772-90.
    View in: PubMed
    Score: 0.004
  82. Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis. Pediatr Diabetes. 2014 Jun; 15(4):287-93.
    View in: PubMed
    Score: 0.004
  83. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabetes Technol Ther. 2013 Nov; 15(11):929-34.
    View in: PubMed
    Score: 0.004
  84. Comparison of autoantibody-positive and autoantibody-negative pediatric participants enrolled in the T1D Exchange clinic registry. J Diabetes. 2013 Jun; 5(2):216-23.
    View in: PubMed
    Score: 0.004
  85. Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr. 2013 Apr; 162(4):736-740.e1.
    View in: PubMed
    Score: 0.004
  86. Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes. 2005 Aug; 54(8):2482-6.
    View in: PubMed
    Score: 0.002
  87. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. Isr Med Assoc J. 2005 Jun; 7(6):381-4.
    View in: PubMed
    Score: 0.002
  88. Pathology teach and tell: vaginal mesonephric papilloma. Pediatr Pathol Mol Med. 2001 Jul-Aug; 20(4):341-4.
    View in: PubMed
    Score: 0.002
  89. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest. 2001 Mar; 107(5):555-64.
    View in: PubMed
    Score: 0.002
  90. Modification of the environment is not the most efficient way to prevent type 1 diabetes. Diabetes Technol Ther. 2000; 2(4):609-16.
    View in: PubMed
    Score: 0.001
  91. [Parenteral nutrition of patients under intensive chemotherapy: comparative study of two lipid emulsions]. Nutr Hosp. 1998 Jul-Aug; 13(4):177-80.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.